Harvard Bioscience's market cap is currently $19.94M. The company's EPS TTM is $-0.01; its P/E ratio is ―; Harvard Bioscience is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
